Name | 2-bromo-1,3-thiazole-4-carbonitrile |
---|---|
Synonyms |
2-bromothiazole-4-carbonitrile
4-Thiazolecarbonitrile, 2-bromo- 2-Bromo-1,3-thiazole-4-carbonitrile 2-BROMO-4-CYANOTHIAZOLE |
Density | 2.0±0.1 g/cm3 |
---|---|
Boiling Point | 276.1±13.0 °C at 760 mmHg |
Molecular Formula | C4HBrN2S |
Molecular Weight | 189.033 |
Flash Point | 120.8±19.8 °C |
Exact Mass | 187.904373 |
PSA | 64.92000 |
LogP | 1.36 |
Vapour Pressure | 0.0±0.6 mmHg at 25°C |
Index of Refraction | 1.651 |
HS Code | 2934100090 |
---|
~% 848501-90-6 |
Literature: WO2011/109799 A1, ; Page/Page column 225 ; |
~% 848501-90-6 |
Literature: KARYOPHARM THERAPEUTICS, INC.; SHECHTER, Sharon; KAUFFMAN, Michael; SANDANYAKA, Vincent, P.; SHACHAM, Sharon Patent: WO2011/109799 A1, 2011 ; Location in patent: Page/Page column 225 ; |
Precursor 1 | |
---|---|
DownStream 0 |
HS Code | 2934100090 |
---|---|
Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |